Bar-Ilan University researchers have identified a three-drug combination that successfully treats Latent Autoimmune Diabetes in Adults (LADA) in approximately 30% of mice tested. The study demonstrates the ability to predict which patients will respond to the treatment, potentially paving the way for personalised medical care and new therapeutic approaches to the condition.

Sources: Times of Israel